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Abstract
Background: Global coverage of prevention of mother-to-child (PMTCT) services reached 53% in 2009. However the
number of pregnant women who test positive for HIV in antenatal clinics and who link into long-term HIV care is not known
in many resource-poor countries. We measured the proportion of HIV-positive pregnant women in Mwanza city, Tanzania,
who completed the cascade of care from antenatal HIV diagnosis to assessment and engagement in care in adult HIV clinics.
Methods: Thirty antenatal and maternity ward health workers were interviewed about PMTCT activities. Nine antenatal HIV
education sessions were observed. A prospective cohort of 403 HIV-positive women was enrolled by specially-trained
clinicians and nurses on admission to delivery and followed for four months post-partum. Information was collected on
referral and attendance at adult HIV clinics, eligibility for highly active antiretroviral therapy (HAART) and reasons for lack of
attendance.
Results: Overall, 70% of PMTCT health workers referred HIV-positive pregnant women to the HIV clinic for assessment and
care. Antenatal HIV education sessions did not cover on-going care for HIV-infected women. Of 310 cohort participants
tested in pregnancy, 51% had received an HIV clinic referral pre-delivery. Only 32% of 244 women followed to four months
post-partum had attended an HIV clinic and been assessed for HAART eligibility. Non-attendance for HIV care was
independently associated with fewer antenatal visits, poor PMTCT prophylaxis compliance, non-disclosure of HIV status, and
non-Sukuma ethnicity.
Conclusion: Most women identified as HIV-positive during pregnancy were not assessed for HAART eligibility during
pregnancy or in the first four months post-partum. Initiating HAART at the antenatal clinic, improved counselling and
linkages to care between PMTCT and adult HIV treatment services and reducing stigma surrounding disclosure of HIV results
would benefit on-going care of HIV-positive pregnant women.
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Introduction
Mother-to-child transmission (MTCT) of HIV has been
virtually eliminated in developed countries through effective
prevention of mother-to-child transmission (PMTCT) pro-
grammes, but, although countries such as Botswana have
demonstrated considerable success in reducing MTCT rates,
significant challenges and gaps in service remain in most
developing countries [1–6]. The 2010 World Health Organisation
PMTCT guidelines recommend that all HIV-positive pregnant
women should be assessed for eligibility to start highly active
antiretroviral therapy (HAART) for their own health via referral to
an HIV care and treatment centre [7]. PMTCT programmes
therefore represent a major opportunity to go beyond the
prevention of infant infections to allow diagnosis and management
of previously-unrecognised maternal HIV infection, and the
prevention of HIV-related orphans. However, this requires that
women navigate a series of steps along the cascade from testing,
diagnosis, assessment for eligibility for life-long HAART, to
initiation of HAART if indicated (Figure 1).
Data from South Africa on the operational performance of
onward referral from PMTCT services of women identified as
HIV-positive in pregnancy suggest that, whilst a high proportion
of pregnant women may be HIV tested and receive ART
prophylaxis for PMTCT at the ANC, a significant proportion
are not assessed during pregnancy for eligibility to receive lifelong
HAART or do not receive HAART if they are assessed as needing
it [8,9]. Linkage to HIV care and treatment following testing at
non-antenatal clinic settings in sub-Saharan Africa has also been a
challenge, including after general provider-initiated testing and
counselling, testing of TB patients and through voluntary
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counselling and testing services [10–14]. As part of a study
examining PMTCT services within public health facilities in
northwest Tanzania, we aimed to measure whether HIV-positive
women identified through PMTCT received appropriate referral
and care for their own health concerning HIV, and to explore
individual and provider barriers that could explain why they did
not attend.
Methods
The study was located in Mwanza city in Tanzania, a low-
income country with an estimated adult HIV prevalence of 5.6%
[15,16]. Mwanza, Tanzania’s second largest city, had a population
of 474,797 at the last census in 2002 [17] and has an estimated
HIV prevalence in pregnant women of 8.4% [18]. Overall, 98% of
Tanzanian pregnant women are reported to attend an antenatal
clinic at least once in pregnancy, approximately 43% to make four
or more visits and 82% of urban women deliver in hospital [19].
Data were collected between September 2008 to July 2009 from
health worker interviews, from observation of PMTCT antenatal
services at three antenatal clinics in Mwanza and from a cohort
study of HIV-positive women recruited at the maternity wards of
two large government hospitals in Mwanza city. These two
hospitals also housed the main adult HIV care and treatment
clinics for the city. All three antenatal clinics had an adult HIV
clinic on site. In two of these sites the HIV clinics had recently
opened. However, because of concern that patients might not like
to attend a clinic near their place of residence, pregnant women
were usually asked where they would like to attend and could be
therefore be referred to HIV clinic services 5–10 km away.
Ethical Considerations
The study was approved by the Ethics Committees of the
Tanzanian National Institute for Medical Research and the
London School of Hygiene & Tropical Medicine. Informed
written or finger-printed consent was obtained from all cohort
participants.
Health Worker Interviews
A structured questionnaire with open and closed questions was
administered to all health workers at the three largest antenatal
clinics and the maternity wards of the two largest government
hospitals in Mwanza city by RB or a trained nurse or clinician
interviewer. Data gathered included key work activities, PMTCT
and other training received, perceived challenges in implementing
PMTCT services and PMTCT-related knowledge.
Cohort Study
We enrolled 403 of 442 HIV positive women admitted for
delivery between September 2008 and February 2009.
HIV status was routinely recorded in the antenatal card that
pregnant women brought with them on admission for delivery and
these results were routinely recorded in the maternity ward
admissions book. All consecutively-admitted eligible HIV-positive
women were seen in private by a counsellor to inform them about
the study. Women were not eligible if they were resident outside
Mwanza city or were unable to provide informed consent. Of the
39 women not enrolled, 27 lived outside Mwanza, 6 refused, 4
were missed, and 2 were unable to give informed consent.
Those who agreed to participate were given further verbal and
written information about the study by a research assistant and
were asked to sign or fingerprint a consent form. They were
interviewed about socio-demographic characteristics, outcomes of
previous pregnancies and past contraceptive use. Information
collected about the current pregnancy included details on
antenatal care, uptake of PMTCT services, referral and
attendance at an adult HIV clinic during that pregnancy, CD4
cell count results if available and HAART status. In the currently-
used 2007 Tanzanian National PMTCT guidelines, eligibility for
HAART is based on a CD4 cell count of less than 200 cells/mm3
or being diagnosed as having WHO Stage 3 or 4 [20]. Women
who are not eligible for HAART should be offered zidovudine
(AZT) from 28 weeks gestation, single dose (sd) nevarapine (NVP)
and 3TC at labor onset and through delivery and continued for
one week post-partum, with the infant receiving sdNVP after
Figure 1. Cascade of referral and care for HIV-positive pregnant women in Tanzan.
doi:10.1371/journal.pone.0040091.g001
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delivery and AZT syrup for 4 weeks (or one week if mother had
received 4 or more weeks of AZT). At the time of the study,
provider-initiated counselling and testing had been introduced
with all women being referred into a PMTCT counsellor at their
first antenatal visit in that pregnancy.
Prior to discharge from hospital, data were collected on whether
the mother had been tested for HIV in the maternity suite and on
any onward referral. Enrolled women were followed up at their
monthly visits at the under-five reproductive and child health
(RCH) clinic or four months post-partum. At each visit,
participants were interviewed about referral, disclosure of HIV
status to others, their progress at the HIV clinic and were asked to
show the interviewer their HIV clinic card which documented
attendance dates, CD4 cell count results by date, and date of
initiation of HAART, if applicable. Those who had not attended
an HIV clinic were asked about reasons for lack of attendance.
They were then re-referred to the counsellor at the RCH clinics to
reiterate why assessment of their own health was important and to
encourage them to attend the HIV clinic for this. They were
followed up at home by a field worker if they did not attend the
clinic visit and had given consent for home visits. If the field
worker believed that the interview could not be conducted in
private at the home then the interview was postponed and the
participant was asked to come to the health facility.
The study aimed to enroll 330 HIV-positive women. Allowing
for a 20% loss to follow-up over four months, it was estimated that
264 women attending the four month visit would allow us to
measure the proportion of HIV-positive pregnant women referred
to and attending an HIV clinic with adequate precision if the
proportion attending HIV clinic services was between 40–70%.
Data Management
Data were double-entered in EpiData 3.1 (Epidata Association,
Odense, Denmark) and cleaned and analysed using Stata 11.0
(STATA Corporation, Texas, USA). Data from the cohort study
were used to determine the proportion of women who successfully
completed the PMTCT/maternal health uptake intervention
cascade. A Piot-Fransen model was built up to show the fall-off
at each step of the referral and assessment cascade. This used the
denominator of women who successfully completed the previous
step based on data from women who tested HIV-positive for the
first time during the current pregnancy and who were seen at the
fourth monthly post-partum follow-up visit. This was to allow
inclusion of women who had complete information up to the end
of the study. This model was adapted from an evaluation model of
case finding and treatment for tuberculosis control programmes
and has been used to evaluate other programmes such as those for
sexually transmitted diseases [21,22].
To identify potential client and provider factors in the cohort
study that were associated with successful completion of the
referral and treatment cascade, crude odds ratios (OR) with 95%
CI were estimated using logistic regression analysis. Factors whose
univariable association with the outcome reached statistical
significance at p,0.1 were included in an initial multivariate
model and retained in the final model if independently associated
with the outcome (p,0.1). Associations with p-values below 0.01
are interpreted as showing strong evidence, p-values around 0.05
as moderate evidence, and p-values around 0.1 as weak evidence.
Results
Cohort Study: HIV Clinic Referral and Attendance
In total, 403 HIV-positive women admitted for delivery were
enrolled. The mean age of cohort participants was 28.3 years
(range 16 to 48 years). Seven women did not know their age.
Overall, 164 (40.7%) were Catholic, 140 (34.7%) were other
Christians, 97 (24.1%) were Muslims and 2 (0.5%) had no religion.
Most (n = 365; 90.6%) had primary school or higher education;
192 (47.6%) were housewives, 196 (48.6%) reported having
unskilled work and 15 (3.7%) reported being in skilled work.
Two hundred and eighty five (70.7%) were married, 47 (11.7%)
were single, 53 (13.2%) were divorced or separated and 18 (4.5%)
were widowed. Two hundred and twenty seven (56.3%) were
Sukuma, the largest ethnic group in Mwanza Region.
Overall 93 of 403 enrolled women reported that they had been
tested and diagnosed with HIV before the current pregnancy and
were excluded from this analysis. Of the remaining 310 women
who tested HIV-positive through PMTCT services, 240 (77.4%)
were tested during pregnancy, 23 (7.4%) were tested at the
maternity ward before delivery, and 47 (15.2%) were tested at the
maternity ward after delivery.
At enrollment, of the 240 women who were tested at antenatal
PMTCT services, 123 (51.3%) had received a referral to an HIV
clinic. Of those referred, 71 (57.7%) had attended prior to delivery
of whom only 36 (50.7%) could confirm their attendance by
providing a clinic card. Only 30 (24.3%) of those referred (83.3%
of those with a clinic card) had evidence of a CD4 test result
(Table 1). Five (16.7%) women had a CD4 cell count result of less
than 200 cells/mm3, three of whom (60.0%) had been started on
HAART.
In total, 70/310 previously-untested HIV-positive women were
tested at the maternity ward (22.6%). No referrals to the HIV
clinic were given by maternity ward staff to HIV-positive women
who had not yet attended HIV care and treatment services,
including those who were identified as HIV-positive for the first
time in the maternity ward.
A total of 244 (79.0%) women were seen at the four month
follow-up visit, and by this time 199 (81.6%) had received referral
to an HIV clinic. Approximately half received this referral pre-
delivery and half received the referral post-delivery, when they
attended the under-five clinic or when they visited the maternity
wards for infant diagnosis (Table 1).
Overall 133 (42.9%) of 310 women were referred to and
attended an HIV clinic within four months post-delivery and 95
(71.4%) of these had a CD4 cell count. Twenty (21.1%) had a
CD4 cell count below 200 cells/mm3 and 13 (65.0%) were started
on treatment sometime between diagnosis and four months post-
partum. Because not all women attended all follow-up visits, the
proportion reporting referral to and attendance at an HIV clinic
and assessment with a CD4 cell count was examined at each visit
(Table 1). The proportion receiving an HIV clinic referral post-
delivery rose with time; 13.6% and 39.7% reported having
received a referral after delivery when they were seen at the first
and fourth post-natal visits, respectively. Of those who had been
referred to an HIV clinic, the proportion who attended a clinic
varied by follow-up visit, ranging from 45.9% at the one month
post-partum visit to 68.0% at the three-month visit. The majority
(64.9%283.3%) of those attending an HIV clinic had had a CD4
cell count test performed, and about 20% had CD4 cell counts
below 200 cells/mm3. Among these women eligible for HAART,
only about half had initiated HAART at each visit.
Using data on the attrition along the patient cascade for HIV-
positive pregnant women who attended the four month follow-up
visit, the Piot-Fransen model (Figure 2) showed that 78 of 244
(32.0%) participants were referred, attended an HIV clinic and
were assessed for their eligibility for HAART. Only 10 of 18
(55.5%) of those eligible for HAART had started it within four
months of delivery.
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To estimate the potential total number in the entire study
population who might have completed the cascade, based on data
from the four month follow-up visit, we excluded 13 women who
did not show their HIV clinic enrollment card during follow-up
visits and therefore had no evidence of actually attending an HIV
clinic. We assumed that the same proportion of women who did
and did not attend an HIV clinic would have been eligible to start
HAART (CD4 cell count less than 200 cells/mm3). Assuming 56
(23.1%) of 244 HIV-positive women were eligible to start HAART
(Figure 2), then only 10 (17.6%) of HIV-positive women who were
eligible for treatment actually navigated all the levels of the system
and received ART within four months of delivery.
Barriers and Factors Associated with Lack of Attendance
at HIV Care and Treatment Services Pre-delivery
At enrollment, 52 (42.2%) of 123 women tested through
PMTCT services who had received a referral to an HIV clinic
prior to delivery had not attended prior to admission. Thirty-eight
women were asked about their reasons for not attending an HIV
clinic (others were not asked because they had not brought their
HIV clinic cards to the maternity ward). Reasons included not
understanding why it was important to attend an HIV clinic soon
after diagnosis (n = 17), too ill to attend (n= 5), afraid to disclose
their HIV status (n = 4), wanting to wait until after delivery (n = 4),
distance to the HIV clinic (n = 2), being informed services were not
available when they attended the HIV clinic (n = 2), lack of time
(n= 1), did not believe the HIV results (n = 1), and not feeling it
was necessary to attend HIV clinic services because she felt well
(n = 1).
By four months post-partum, 199 women had been referred to
an HIV clinic but 76 had not attended. On univariate analysis,
there was strong evidence of an association of non-attendance was
associated with being of non-Sukuma ethnicity, not having
disclosed HIV status and poor compliance with PMTCT ART
prophylaxis, moderate evidence of an association with having
fewer antenatal visits, and weak evidence of an association with
being Muslim and a primigravida (Table 2). On multivariate
analysis (Table 3), lack of attendance at an HIV clinic was
independently associated with failing to disclose HIV status
(aOR=3.06, 95%CI: 1.69–7.74), being of non-Sukuma ethnicity
(aOR=2.47, 95%CI: 1.28–4.76), and, to a lesser extent, with poor
compliance with PMTCT ART prophylaxis (aOR=2.13, 95%
CI: 1.13–4.04), and having made fewer than 3 antenatal visits
during pregnancy (aOR=1.78, 95% CI: 0.93–3.38).
Challenges to implementation that were mentioned included a
lack of tracking systems to record whether women were referred
and attended an HIV clinic. Health workers reported that,
because adult HIV care and treatment services were busy,
pregnant women often were not enrolled and assessed for
eligibility for HAART during pregnancy. One health worker
reported that a particular HIV clinic also sometimes refused to
enroll women who had been sent from the maternity ward to the
HIV clinic in the same hospital during their admission for delivery.
The HIV clinic staff mistakenly assumed that HIV-positive
pregnant women had received all the care they required at the
antenatal PMTCT services or in the maternity ward. There were
few suggestions on how the system might be improved, but those
mentioned included asking PMTCT health workers to accompany
pregnant women to an HIV clinic, and designated HIV care and
treatment services for pregnant women.
Clinic Observations
In total, 134 pregnant women attended the nine observed
antenatal HIV education sessions, facilitated by a nurse in Swahili.
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The average length and average number of participants for the
sessions was 26 minutes (range 15 to 35 minutes) and 15 (range 7
to 22), respectively. No participants asked any questions in four of
these sessions. Most questions in other sessions focused on
PMTCT, and women were interested to learn about the
effectiveness of ART for PMTCT. However, there were no
questions about interventions that focused on the woman’s own
health if she tested positive despite this not being mentioned in any
of the sessions.
Discussion
Key Findings
Current WHO guidelines recommend that HIV-infected
pregnant women should be initiated on HAART for their own
health if their CD4 cell count is less than 350 cells/mm3 or if they
are in WHO clinical stage 3 or 4 [23]. HIV testing is the key entry
point to HIV care for both mother and child, and initiation of
HAART, if required, should be done as soon as possible in
pregnancy in order to give optimal health outcomes for both
mother and child. It is clear from our study that, irrespective of the
specific CD4 cell count threshold for initiating treatment, the
majority of women testing HIV-positive at the main antenatal
clinics in Mwanza who require HAART were unable navigate and
complete the complex cascade of steps needed to ensure they start
HIV treatment in pregnancy, even where PMTCT services and
HIV treatment clinics were in the same town or even in the same
hospital. At the pre-natal stage, attrition in the cascade was
particularly severe between testing and receiving a referral to and
initial attendance at an HIV clinic, being assessed for HAART
eligibility and receiving HAART if eligible. The proportion
receiving a referral improved with time since HIV testing for those
staying in post-natal care but HIV clinic attendance, assessment
and initiation of HAART continued to be problematic. If these
findings are similar across other regions in the country, then with
an HIV prevalence in antenatal attenders of 8.4% [18], the
number of women who were not linked into long-term care in
Tanzania will be substantial. Furthermore, the infants of many
HAART-eligible women would not have received the most
effective regimen for PMTCT if their mothers were significantly
immuno-suppressed. In our setting fewer than 18% of pregnant
women potentially eligible for HAART were assessed and initiated
on HAART between HIV diagnosis in pregnancy and four
months after delivery. Similar loss across the HIV diagnosis-
treatment cascade has been observed in Kenya and other
countries [24–27].
Figure 2. Attrition in the cascade of HIV assessment and treatment steps taken by women identified as HIV positive through
PMTCT services.
doi:10.1371/journal.pone.0040091.g002
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Concerns that the health of mothers has been neglected in
PMTCT programmes have been raised previously, since pro-
gramme emphasis had largely focused on preventing transmission
to infants [28]. In our study, failures in the intervention steps were
observed at several levels. Nearly half of all HIV-positive women
who delivered in hospital had not been referred to an HIV clinic
Table 2. Baseline factors at enrolment & univariate analysis of factors associated with not attending an HIV clinic four months post
delivery.
Variable Total at enrolment
Total seen at 4 months
post-delivery
Not attended HIV clinic
by 4 months post-delivery Crude OR 95% CI P
N=403 % N=199 % n=76 %
Age1
,30 years 242 61.1 122 61.3 52 41.9 1
.= 30 years 154 38.9 75 37.7 24 32.0 0.65 0.35–1.18 0.16
Ethnicity
Sukuma 176 43.7 85 42.7 23 27.1 1
Non-Sukuma 227 56.3 114 57.3 53 46.5 2.34 1.28–4.28 0.005
Religion
Christian 304 75.4 152 76.4 53 34.9 1
Muslim 97 24.1 47 23.6 23 48.9 1.34 0.96–1.86 0.08
No religion 2 0.5 0 - 0 -
Education level
No school 38 9.4 17 8.5 7 41.2 1
Primary or higher 365 90.6 182 91.5 69 37.9 1.14 0.42–3.15 0.79
Occupation
Unskilled/at home 388 96.3 188 94.5 72 38.3 1
Skilled work 15 3.7 11 5.5 4 36.4 0.97 0.63–1.48 0.90
Marital status
Married 285 70.7 147 73.9 57 38.8 1
Not currently married 118 29.3 52 26.1 19 36.5 0.91 0.47–1.74 0.78
Gravidity
Primigravidae 70 17.4 40 20.1 20 50.0 1
Multigravidae 333 82.6 159 79.9 56 35.2 0.54 0.27–1.09 0.09
HIV status disclosed
Yes 1302 36.5 157 78.9 51 32.5 1
No 2262 63.5 42 21.1 25 59.5 3.06 1.51–6.16 0.001
Partner tested for HIV
Yes 112 27.8 68 34.2 21 30.9 1
No 291 72.2 131 65.8 55 42.0 1.69 0.87–3.01 0.13
Number of ANC visits
3 or more visits 2333 39.9 124 62.3 40 32.2 1
1 or 2 visits 1553 60.1 75 37.7 36 48.0 1.94 1.08–3.49 0.03
Took PMTCT ART
Yes 260 27.0 127 63.8 38 29.9 1
No 96 73.0 72 36.2 38 52.8 2.62 1.44–4.76 0.001
Ever used contraception3
Yes 208 51.6 93 46.7 39 41.9 1
No 195 48.4 106 53.3 37 34.9 0.74 0.42–1.32 0.31
Infant alive at 4 months
Yes NA 179 89.9 67 37.4 1
No 20 10.1 9 45.0 1.37 0.54–3.47 0.51
1Excludes 7 women with unknown age.
2Excludes 47 women who were tested on admission for delivery.
3Excludes 15 women with no ANC card available at the maternity ward.
4Oral and injectable hormonal contraception, condoms and intrauterine contraceptive device.
doi:10.1371/journal.pone.0040091.t002
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prior to delivery. None of the HIV-positive women tested at the
maternity ward received a referral to an HIV clinic before
discharge from the hospital, and many women, who had shown
willingness to access health services by attending up to four post-
natal RCH visits, were still not referred to or had attended an HIV
clinic. Furthermore, women were rarely asked whether they had
been referred to or had attended these services. Many did not
bring their HIV clinic cards to the maternity suite or to their RCH
clinic visits, making it difficult for maternity and RCH staff to
confirm who had or had not been linked into the adult HIV
treatment services.
Individual-level Factors and Lack of Attendance at an HIV
Clinic
Women who did receive referrals to an HIV clinic described a
number of barriers to attending during pregnancy, such as lack of
understanding why they should attend and fear of disclosure of
their HIV status. The latter can be associated with stigma which
has been shown to influence willingness to access HIV treatment
services in other studies [29–31]. In addition to lack of disclosure,
which has been associated with lack of attendance at services in
some, but not all, studies [27,31], both ethnic group and religion
were associated with lack of attendance at a clinic. Ethnicity has
been associated with health-seeking behaviours in previous studies
in Tanzania [32,33]. The Sukuma are the traditional residents of
Mwanza Region. Women from other ethnic groups may have
different economic or educational status or different cultural
beliefs related to health care, HIV infection and its treatment, all
of which might influence their uptake of HIV services. Muslim
women were also less likely to attend an HIV clinic in the city than
non-Muslim women, again perhaps because socio-cultural norms
preclude them from seeking on-going care for this stigmatising
disease [34].
Delays in accessing care after diagnosis amongst adult HIV
patients are common in sub-Saharan Africa [35–37]. In one study
of 701 Kenyan HIV-positive patients, 31.4% had delayed seeking
care for over six months and 21.8% for over one year [38]. Being
female, non-disclosure of HIV status and distances between the
testing centres and the HIV care and treatment centres were
associated with delayed attendance for HIV care. Only 35% of
HIV-positive pregnant women in Kinshasa attended an HIV clinic
within a median time of 4.5 months after HIV diagnosis [39]. The
median time between HIV diagnosis and attendance was 2.5
months. Distance to the clinic, transportation costs, travel and
non-disclosure were cited as the commonest reasons for missed
visits. In our study, in addition to these four issues, infrequent
antenatal clinic attendance was also strongly associated with lack
of attendance for on-going care. Strategies to encourage disclo-
sure, such as offering antenatal clinic couple counselling and
testing services and improved support to women who are
considering disclosure, should therefore be considered [40–42].
Provider-level Factors and Lack of Attendance at an HIV
Clinic
Lack of understanding among staff about when women should
be referred after being given their HIV results is likely to have
contributed to the low referral rate. Inadequate health worker
knowledge was found to impact on a number of steps in the
PMTCT care continuum in South Africa [43], and health workers
in Malawi also sometimes failed to refer asymptomatic women to
HIV clinics [44]. The majority of health workers in our study were
aware of the HIV referral system but there were basic
misunderstandings in how this should be implemented and it
was unclear what post-test counselling messages had been
delivered to mothers concerning maternal care. Content of
HIV-related educational messages was also important. The
Tanzanian national PMTCT guidelines on the information to
be given during pre-test counselling focus on the benefits of HIV
testing, MTCT, disclosure and the importance of assessing the
mother for eligibility for HAART [20]. However this latter
recommendation is not reinforced in antenatal HIV education
sessions. Since women demonstrated a lack of understanding
about the need to attend an HIV clinic for assessment soon after
diagnosis, it is clear that strengthening antenatal and post-natal
training and counselling will be essential to reinforce key messages
about on-going health care for HIV-positive pregnant women. In
addition, improvement of PMTCT services in the maternity suites
will be essential to allow newly diagnosed HIV-positive women to
receive information regarding their HIV-positive status and on-
going care before discharge from the labour ward.
Recommendations
There is evidence that HAART in pregnancy provides a
substantially greater reduction in MTCT of HIV compared with
simpler regimens. In South Africa, for example, MTCT of HIV
was 11–13% with single-dose NVP compared to 0.3% in women
who received more than 7 weeks of HAART [45,46]. A combined
analysis in South and West African cohorts of transmission
through breastfeeding showed that there was a 5% cumulative risk
of transmission to the infant even in women with high CD4 cell
counts [47]. This would argue for countries to consider
implementing the WHO Option B, where HAART may be
started at ANC services irrespective of CD4 cell count, and
continued until one week after breastfeeding has ended in women
who are not eligible for lifelong HAART under current treatment
guidelines [7]. This regimen allows the infant maximum protec-
tion from vertical transmission and ensures that women who do
require HAART for their own health have an opportunity to start
this as early as possible after diagnosis of their positive HIV status,
without having to wait for their CD4 cell count test result [47,48].
This is important since late treatment initiation in Africa has been
associated with higher mortality [49,50].
Table 3. Independent factors associated with not attending
an HIV clinic four months post delivery1.
Variables
Adjusted
OR1 95% CI P
Ethnicity
Sukuma 1
Non-Sukuma 2.47 1.28–4.76 0.006
Number of ANC visits during
pregnancy
3 visits or more 1
1 or 2 visits 1.78 0.93–3.38 0.08
Took PMTCT tablets
Yes 1
No 2.13 1.13–4.04 0.02
Disclosure of HIV status
Yes 1
No 3.06 1.69–7.74 0.001
1Adjusted for age, tribe, total ANC visits during pregnancy, whether PMTCT
medication was taken and disclosure of HIV status to any other person.
doi:10.1371/journal.pone.0040091.t003
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Even with WHO Option B, improvement in linkages between
services will still be required to ensure that women are assessed to
determine whether they need to stay on HAART after breastfeed-
ing and to ensure they are linked into HIV care and support
services to monitor their own health. Whilst our study demon-
strated the importance of continuing to deliver information post-
partum about enrollment into HIV treatment services, steps to link
women into HIV care will have to happen more promptly and
efficiently in order to avoid treatment interruptions. HAART may
therefore need to be available at both ANC and RCH post-
delivery services if these are not integrated. Strategies such as the
mothers2mothers program which works with HIV-positive ‘‘mentor
mothers’’ may also be effective in offering HIV-infected pregnant
women additional support as they transition between ANC and
adult HIV care and treatment services [51–53]. This could be
especially valuable as women testing HIV-positive through
antenatal services in Mwanza Region currently receive little or
no psycho-social support. Decentralising HIV treatment services is
underway in Tanzania and increasing availability of HIV care,
especially in rural areas, and task-shifting to allow nurses to
prescribe ART, may also improve linkage to care and more rapid
initiation of treatment.
Study Strengths and Limitations
Strengths of our study were the prospective cohort design and
multiple data collection methods. Limitations include the fact that
cohort participants were enrolled at delivery, and therefore the study
did not include pregnant women testing HIV-positive in antenatal
services butwhodidnotdeliver inhospitals. Inaddition,women from
remote rural areas in Tanzania were not included and we were not
able to determine if women lost in the treatment cascade sought care
elsewhere.Wehave assumed that the proportionofHAART-eligible
women who not attend an HIV clinic is the same as those who do
attend a clinic but this assumptionmay be incorrect. The proportion
ofwomenwhoreportedreceivingareferral toanHIVclinic increased
post-partum, and it is possible that the research team contributed to
this improvement.
Conclusion
In conclusion, we observed multiple missed opportunities to link
HIV-positive pregnant women into HIV treatment programmes.
Changes in the training and supervision of health workers
implementing PMTCT and health system modifications are
needed for staff to successfully enable women who test HIV-
positive during antenatal or delivery care to access HIV treatment
and care services for their own health, and to identify women who
have not been assessed. Initiating HAART at the ANC for all
pregnant women should reduce MTCT and maximise the health
benefits for women who require HAART for their own care.
Further research should be conducted to explore the effectiveness
of these interventions and to explore the barriers to attending HIV
care and treatment that pregnant women or mothers face when
they leave PMTCT services, since linkage between the services will
be essential at some point during pregnancy or the post-partum
period.
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